Oxfordshire Clinical Commissioning Group
Formulary
 
back
9 Nutrition and blood
09-01-03 Iron overload

Deferasirox Exjade®
Formulary
  • For the treatment of iron overload for transfused and non transfused patients with chronic inherited anaemias as per NHSE Policy 16070/P. Funded by specialised commissioning (APCO November 2009).
  • Approved at MMTC as 2nd line in myelodysplastic syndromes (MDS). In line with TVPC policy on Iron Chelating Drugs in MDS (APCO May 2019).

 


Red View adult BNF  View SPC online  View childrens BNF  HCD
Deferiprone Ferriprox®
Formulary

For use by Haematology only.

Funded by specialised commissioning.

APCO March 2006.


Red View adult BNF  View SPC online  View childrens BNF  HCD
Desferrioxamine Mesilate Desferal®
Formulary

Secondary care use only for iron overload.

Funded by specialised commissioning.

APCO March 2006.


Red View adult BNF  View SPC online  View childrens BNF